Log in
Enquire now

List of SBIR/STTR awards granted to BioMarck Pharmaceuticals

List of SBIR/STTR awards granted to BioMarck Pharmaceuticals
List of SBIR/STTR awards granted to Dolphin Technology, Inc.
List of SBIR/STTR awards granted to PSEUDOLITHIC, INC.
List of SBIR/STTR awards granted to Energy Science Laboratories, Inc.
Legal technology venture capital investors
Companies in the HR services industry
where
SBIR/STTR Award Recipient
is
BioMarck PharmaceuticalsBioMarck Pharmaceuticals
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
BIOMARCK PHARMACEUTICALS, LTD STTR Phase I Award, September 2019

A STTR Phase I contract was awarded to BioMarck Pharmaceuticals in September, 2019 for $197,556.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

BioMarck Pharmaceuticals
BioMarck Pharmaceuticals
National Institutes of Health
National Institutes of Health
STTR
1R41EY030832-01
Phase I
197,556
September 30, 2019
sbir.gov/node/1686663
‌
BIOMARCK PHARMACEUTICALS, LTD SBIR Phase II Award, August 2013

A SBIR Phase II contract was awarded to BioMarck Pharmaceuticals in August, 2013 for $3,000,000.0 USD from the U.S. Department of Health & Human Services.

BioMarck Pharmaceuticals
BioMarck Pharmaceuticals
SBIR
2R44HL073591-07
Phase II
3,000,000
August 1, 2013
sbir.gov/node/1031841
‌
BIOMARCK PHARMACEUTICALS, LTD SBIR Phase II Award,

A SBIR Phase II contract was awarded to BioMarck Pharmaceuticals for $3,000,000.0 USD from the U.S. Department of Health & Human Services.

BioMarck Pharmaceuticals
BioMarck Pharmaceuticals
SBIR
2R44HL073591-07
Phase II
3,000,000
sbir.gov/node/678830
‌
BIOMARCK PHARMACEUTICALS, LTD SBIR Phase I Award,

A SBIR Phase I contract was awarded to BioMarck Pharmaceuticals for $100,000.0 USD from the U.S. Department of Health & Human Services.

BioMarck Pharmaceuticals
BioMarck Pharmaceuticals
SBIR
1R43HL073591-01
Phase I
100,000
sbir.gov/content/inhibition-mucin-secretion-murine-model-asthma-0
‌
BIOMARCK PHARMACEUTICALS, LTD SBIR Phase II Award,

A SBIR Phase II contract was awarded to BioMarck Pharmaceuticals for $2,990,000.0 USD from the U.S. Department of Health & Human Services.

BioMarck Pharmaceuticals
BioMarck Pharmaceuticals
SBIR
2R44HL073591-04
Phase II
2,990,000
sbir.gov/content/clinical-development-therapeutic-agent-copd-0
5 results
0 selected
5 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us